TheKicksShrink
TheKicksShrink
Minisode 82: Is Strattera Good for ADHD? Psychiatrist Reviews!
Minisode 82: Is Strattera Good for ADHD? Psychiatrist Reviews!
Minisode 82: Is Strattera Good for ADHD? Psychiatrist Reviews!
Wednesday 31st July 2024
Dr. Sulman Aziz Mirza reviews Strattera for ADHD, comparing it to stimulants and discussing benefits, risks, and alternatives.
Explicit
12 minutes
Informative
Educational
Supportive
Honest
Engaging
About this podcast
Author:
TheKicksShrink
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Recovery from Trauma
Mindfulness & Technology in Health
Sexual Stigmas & Myths
Links:
Visit site
Episodes:
121 (View all)
Do you want to link to this podcast?
Get the buttons here!Strattera: A Deep Dive into Non-Stimulant ADHD Medication
Episode Overview
- Strattera is a non-stimulant ADHD medication that works as a selective norepinephrine reuptake inhibitor (SNRI).
- It provides continuous symptom relief over 24 hours but can take up to eight weeks to reach full effect.
- Strattera is non-addictive, making it suitable for individuals with a history of substance misuse.
- Potential side effects include abdominal pain, appetite loss, fatigue, and serious risks like liver issues and suicidal thoughts.
- Alternative non-stimulant options include Qelbree, clonidine, and guanfacine.
"Strattera stands out in the ADHD medication landscape - it's not your typical stimulant like Adderall or Ritalin."
Strattera, a non-stimulant ADHD medication, often sparks curiosity and questions. In this episode of TheKicksShrink Podcast, Dr. Sulman Aziz Mirza, a triple board-certified psychiatrist, takes a deep dive into Strattera's effectiveness, side effects, and how it stacks up against stimulant medications like Adderall and Ritalin. Dr. Mirza explains Strattera's unique mechanism as a selective norepinephrine reuptake inhibitor (SNRI) and discusses its benefits, such as being non-addictive and providing continuous symptom relief over 24 hours.
However, he also doesn't shy away from addressing potential drawbacks, including the risk of liver issues and suicidal thoughts, particularly in children and adolescents. The episode also covers alternative non-stimulant options like Qelbree, clonidine, and guanfacine, providing a comprehensive guide for those exploring ADHD treatments beyond stimulants. Dr. Mirza's balanced approach ensures you get a well-rounded view of Strattera's pros and cons, making it easier to discuss with your healthcare provider.
Whether you're considering Strattera or just want to know more about ADHD medications, this episode offers valuable insights and practical advice. Tune in to find out if Strattera could be the right choice for you or someone you care about.